PAB 0.00% 0.7¢ patrys limited

Ann: Positive preclinical data for deoxymabs in vasculitis, page-3

  1. 9,731 Posts.
    lightbulb Created with Sketch. 25465

    ”…could provide a very attractive therapeutic option for patients. It is particularly exciting to see the potential opportunities to develop or partner our deoxymab technology expand

    while our GMP manufacturing of PAT-DX1 is underway and nearing completion.”

    Dr. Campbell - 9.4.24

 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $14.40M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $18.65K 2.665M

Buyers (Bids)

No. Vol. Price($)
3 80873 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 1638632 8
View Market Depth
Last trade - 15.31pm 27/06/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.